UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

__________________________________________

FORM 8-K

__________________________________________

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 2524, 2026

__________________________________________

Alight, Inc.

(Exact name of Registrant as Specified in Its Charter)

__________________________________________


Delaware	001-39299	86-1849232
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)

320 South Canal Street,
50th Floor, Suite 5000, Chicago, IL		60606
(Address of Principal Executive Offices)		(Zip Code)

Registrant’s Telephone Number, Including Area Code: (224)737-7000

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

__________________________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading

Symbol(s)

Name of each exchange on which registered

Class A Common Stock, par value $0.0001 per share

ALIT

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Item 53.0201 Notice ~~Departure~~ of ~~Directors~~Delisting or ~~Certain~~Failure ~~Officers;~~to ~~Election~~Satisfy ofa ~~Directors;~~Continued ~~Appointment~~Listing ofRule ~~Certain~~or ~~Officers~~Standard; ~~Compensatory~~Transfer ~~Arrangements~~ of ~~Certain Officers~~Listing.

~~Approval~~On March 24, 2026, Alight, Inc. (the “Company” or “Alight”) received a written notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) that it was not in compliance with the continued listing standard set forth in Section 802.01C of ~~Equity~~the ~~Award~~NYSE’s ~~Grants~~Listed Company Manual (“Section 802.01C”), as the average closing price of the Company’s Class A common stock, par value $0.0001 per share (the “Common Stock”), was less than $1.00 per share over a consecutive 30 trading-day period ending March 20, 2026. The Notice does not affect the Company’s ongoing business operations or its U.S. Securities and Exchange Commission reporting requirements and has no immediate impact on the listing of the Company’s Common Stock on the NYSE, subject to the Company’s compliance with the NYSE’s other continued listing requirements.

~~Effective~~The ~~March 25,~~Company ~~2026,~~has responded to the ~~Compensation~~NYSE ~~Committee~~with ~~(the~~respect ~~“Committee”)~~to ofits commitment to cure the ~~Board~~deficiency ofand ~~Directors~~that ofit ~~Alight~~is considering available alternatives including, ~~Inc.~~but ~~(the~~not ~~“Company”)~~limited ~~approved~~to, a ~~grant~~reverse ofstock ~~performance-vesting~~split, ~~restricted~~subject ~~stock~~to ~~units~~stockholder ~~for~~approval no later than at the Company’s ~~named~~next ~~executive~~annual ~~officers~~meeting (of stockholders. Pursuant to Section 802.01C, the ~~“TVR~~Company ~~Awards”)~~has ~~and~~a ~~certain~~period ~~other~~of ~~key~~six ~~employees~~months ~~under~~following the ~~Company’s~~receipt ~~2021~~of ~~Omnibus~~the ~~Plan~~Notice (to regain compliance with the ~~“Plan”)~~minimum share price requirement. The ~~Committee~~Company ~~issued~~may regain compliance at any time during the ~~TVR~~six-month ~~Awards~~cure toperiod ~~incentivize~~if ~~strong~~on ~~financial~~the ~~performance~~last bytrading day of any calendar month during the ~~Company~~six-month ~~and~~cure ~~determined~~period the ~~structure~~Common Stock has a closing share price of ~~such~~at ~~grants~~least in$1.00 ~~consultation~~and ~~with~~an ~~Mercer,~~average ~~its~~closing ~~external,~~share ~~independent~~price ~~compensation~~of ~~consultant~~at ~~after~~least ~~benchmarking~~$1.00 ~~compensation~~over tothe 30 trading-day period ending on the ~~Company’s~~last ~~peer~~trading ~~group~~day ~~among~~of ~~other~~that ~~factors~~month.

~~The~~7.01 Regulation ~~Committee~~FD ~~approved the following grants for the named executive officers:~~ Disclosure.

Name			Shares Subject to TVR Award
Rohit Verma			7,000,000
Martin Felli			1,250,000

As required by Section 802.01C, the Company issued a press release on March 27, 2026 announcing that it had received the notice from the NYSE described in Item 3.01 of this Current Report on Form 8-K (the “Report”) and that the Company intends to regain compliance.

~~The~~A ~~TVR~~copy ~~Awards are eligible to vest based on the achievement~~ of ~~certain~~this ~~stock~~press ~~price~~release ~~milestones~~is atfurnished ~~any~~as ~~time~~Exhibit ~~between April~~ 99.1, ~~2026 and the earlier~~ to ~~occur~~this ofReport. ~~December~~The ~~31,~~information ~~2030 or a change~~ in ~~control~~Item ~~(the “Measurement Period”)~~7.01 ~~The~~and ~~stock~~Exhibit ~~price~~99.1 ~~milestones allow a pro rata portion~~ of ~~the~~this ~~TVR~~Report ~~Awards~~is intended to ~~vest~~be onfurnished aand ~~linear~~shall ~~basis~~not ~~within~~be ~~each~~deemed ~~vesting~~“filed” ~~tranche~~for aspurposes toof upSection to18 ~~25%~~ of the ~~award~~Securities ~~when~~Exchange ~~the~~Act ~~volume-weighted~~of ~~average~~1934, ~~price~~as ~~per~~amended ~~share~~ (the “~~VWAP~~Exchange Act”), ofnor ~~the~~shall ~~Company’s~~it ~~Class~~be Adeemed ~~Common~~incorporated ~~Stock,~~by ~~par~~reference ~~value~~in ~~$0.0001 per share, for~~ any ~~twenty~~filing ~~(20)~~under ~~consecutive trading day period exceeds~~ the ~~minimum~~Securities ~~target~~Act ~~stock~~of ~~price~~1933, ~~for~~as ~~the~~amended, ~~indicated~~or ~~tranche. The Committee will certify~~ the ~~Company’s~~Exchange ~~stock~~Act, ~~price~~except ~~performance~~as ~~after~~expressly ~~each~~set ~~calendar~~forth ~~quarter~~by tospecific ~~determine~~reference ~~the~~in ~~shares~~such ~~to be awarded for the prior quarter’s performance~~filing. ~~The stock price tranche target ranges are as follows:~~

Tranche	Minimum Highest 20-day VWAP	Maximum Highest 20-day VWAP	Percentage Earned at Maximum Achievement
1	$1.50	$2.25	25%
2	$2.25	$3.00	25%
3	$3.00	$3.75	25%
4	$3.75	$4.50	25%

Item 9.01 Financial Statements and Exhibits.

If the highest achieved 20-day VWAP in any calendar quarter falls between the stated minimum and maximum achievement levels for a particular vesting tranche, the executive will earn a pro-rata portion of that vesting tranche (~~to the extent not previously earned~~d) ~~and will remain eligible to vest into the remaining unearned portion of that vesting tranche and other vesting tranches in subsequent quarters based on future stock price performance~~Exhibits. For example, if the VWAP Average for a 20 consecutive trading day period at the end of Q3 2026 is $1.875 (and did not exceed $1.50 in a prior calendar quarter), which is exactly halfway (or 50%) between the minimum and maximum highest 20-day VWAP of Tranche 1, the executive will vest into 12.5% of the executive’s TVR Award (50% of the 25% available in Tranche 1) based on the Q3 2026 performance, subject to also satisfying the continued employment vesting condition. The remaining 12.5% of the TVR Award available for the Tranche 1 VWAP price range (in addition to portions of the TVR Award covered by Tranches 2, 3 and 4) will then remain available for vesting in subsequent calendar quarters within the Measurement Period if the 20-day VWAP in such future quarter exceeds $1.875. Once shares are vested for a particular VWAP price threshold, additional TVR Award shares may only vest for achievement of higher VWAP levels in subsequent calendar quarters before the end of the Measurement Period.

An executive generally must remain actively employed through the last day of a calendar quarter in order to vest in any incremental portion of the TVR Award based on stock price performance within that calendar quarter, provided that in the event of an executive’s termination due to death or disability within a calendar quarter, the executive will remain eligible to vest in the incremental portion of the TVR Award that is earned for that calendar quarter based on actual stock price performance. Vested TVR Award shares generally must be retained by the executive for twelve months after the vested shares are received, subject to certain exceptions in the case of death, disability, estate planning transfers or a change in control.


Exhibit No.						Description
99.1						Press Release of the Company dated as of March 27, 2026
104						The cover page from the Current Report on Form 8-K formatted in Inline XBRL.

~~The Measurement Period will end automatically upon the occurrence of a change in control, and the Company’s stock price achieved upon such change in control will be deemed to equal the 20~~Forward-~~day~~Looking ~~VWAP for that calendar quarter if the change in control stock price exceeds the actual highest achieved 20-day VWAP for that calendar quarter.~~Statements

This Report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include, but are not limited to, Company’s intentions regarding regaining compliance with the minimum price condition of NYSE and the Company’s intended methods to cure such related deficiency. In some cases, these forward-looking statements can be identified by the use of words such as “outlook,” “believes,” “expects,” “potential,” “continues,” “may,” “will,” “would,” “should,” “could,” “seeks,” “projects,” “predicts,” “intends,” “plans,” “estimates,” “anticipates” or the negative version of these words or other comparable words. Such forward-looking statements are subject to various risks and uncertainties including those described in the forward-looking statements can be found under the section entitled “Risk Factors” of Alight’s Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the “SEC”) on February 24, 2026, as such factors may be updated from time to time in Alight's filings with the SEC, which are, or will be, accessible on the SEC's website at www.sec.gov. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. These factors should not be construed as exhaustive and should be considered along with other factors noted in Alight’s filings with the SEC. Alight undertakes no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise, except as required by law.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

			Alight, Inc.
Date:	March 2627, 2026	By:	/s/ Martin Felli
			Martin Felli, Chief Legal Officer and Corporate Secretary

Filing Compare · Alight, Inc. / Delaware